Investor Relations

• H1 2025 Group sales at $14.5 billion, flat versus prior year (+2% at CER)
  • Q2 Group sales at $7.2 billion
• Strong H1 2025 EBITDA growth at $2.5 billion, +24% (+29% at CER) versus prior year period
  • Q2 EBITDA at $1.1 billion
• EBITDA margin recovery thanks to continued focus on enhancing productivity, cost management and operational efficiency
• Profit growth driving stronger H1 cash flow performance
• Sustained demand for new crop protection technologies and biological products as crop protection market recovery continues
• Syngenta will continue to invest in innovation; in total, globally over 800 product approvals in H1 for crop protection business

• Q1 2025 Group sales of $7.3 billion, -1% versus prior year (+3% CER)
• Q1 2025 EBITDA at $1.4 billion, +18% versus prior year (+26% CER)
• EBITDA margin 19.9%, +3.2% points up on prior year
• Robust Crop Protection sales performance during the quarter as channel destocking ends and driven by growth in new crop protection technologies; continued strong growth in China

Resilient seed market, strong growth in new products, and robust performance in China helped offset an overall challenging crop protection market with continued channel destocking; strong cash generation and double-digit EBITDA improvement in Q4